Insider Trading & Ownership - Arbet-Engels Christophe

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Arbet-Engels Christophe

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-13
Option Award(A)
2024-02-28
5:52 pm
N/A
2034-02-13
X4 Pharmaceuticals IncXFORArbet-Engels Christophe
Chief Medical Officer
180,816$0180,816
(Direct)
View
2024-02-13
Option Award
2024-02-16
5:11 pm
N/A
2034-02-13
X4 Pharmaceuticals IncXFORArbet-Engels Christophe
Chief Medical Officer
475,831$0475,831
(Direct)
View
2023-08-31
Option Award
2023-09-05
4:15 pm
N/A
2033-08-30
X4 Pharmaceuticals IncXFORArbet-Engels Christophe
Chief Medical Officer
1,250,000$1.281,250,000
(Direct)
View
2020-05-25
Option Award
2020-05-27
9:38 pm
N/A
2030-05-24
Millendo Therapeutics Inc.MLNDArbet-Engels Christophe
Chief Medical Officer
80,000$080,000
(Direct)
View
2020-02-10
Option Award
2020-02-11
5:02 pm
N/A
2030-02-09
Millendo Therapeutics Inc.MLNDArbet-Engels Christophe
Chief Medical Officer
140,000$0140,000
(Direct)
View
(A) Indicate amendment filing.